Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00107835Phase 3Completed
A Phase 3 trial of lidocaine 10% oropharyngeal spray, tetracaine in pain, sponsored by ZARS Pharmaceuticals. Started May 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00107835.